| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/22/2005 | US20050208641 Mutants of MAW motifs of RecA protein homologs method of making them, and their uses |
| 09/22/2005 | US20050208638 Process for preparing bioactive protein-enriched whey products |
| 09/22/2005 | US20050208634 nucleotides that code proteins involved in one-carbon compounds metabolism, derived from microorganisms belonging to methylotrophic bacteria |
| 09/22/2005 | US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/22/2005 | US20050208626 SGIP peptides |
| 09/22/2005 | US20050208624 Fluorescent protein |
| 09/22/2005 | US20050208622 50 human secreted proteins |
| 09/22/2005 | US20050208621 Nucleotide sequences coding serine threonine kinase for identifying modulators for prevention and treatment of inflammation, endocrine and nervous system disorders |
| 09/22/2005 | US20050208620 Nucleic acid sequence encoding epothilone B hydroxylase and recombinent microorganisms containing the sequence |
| 09/22/2005 | US20050208619 29 human secreted proteins |
| 09/22/2005 | US20050208618 Nucleotide sequences coding thrombospondin metalloproteinase-like-thrombospondin type 1 (ITGL-TSP) protein for identifying modulators to treat and prevent diabetes, restenosis, alzheimer's, cell proliferative and cardiovascular disorders |
| 09/22/2005 | US20050208617 Human-like glycoproteins; for hydrolysis of oligosaccharide substrates for N-glycan processing in secretory pathway |
| 09/22/2005 | US20050208610 Method of producing an anticoagulation effect |
| 09/22/2005 | US20050208605 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 09/22/2005 | US20050208600 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics |
| 09/22/2005 | US20050208591 Antibodies to chemokine alpha-6 |
| 09/22/2005 | US20050208587 Fab 4E10/KGND crystal complex for use in preparing viricidal agents; rational drug design |
| 09/22/2005 | US20050208584 Using modified thanatos-associated-protein-1 (THAP1) for treatment and prevention of inflammation, arthritis and inflammatory bowel diseases |
| 09/22/2005 | US20050208583 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/22/2005 | US20050208578 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
| 09/22/2005 | US20050208577 Using reporter molecule expression as diagnostic tool in monitoring interacting sets of molecules |
| 09/22/2005 | US20050208574 Modified pore-subunit polypeptide covalently linked to sensing moiety for use in detection and/or measurement of analytes or physical characteristics of samples |
| 09/22/2005 | US20050208572 Nucleotide sequences coding interleukin receptor (EV127) for use in identifying modulators for and treatment of cell proliferative disorders; cancer diagnostic and treatments |
| 09/22/2005 | US20050208571 Nucleotide sequences coding animal hydrolases for use in identifying modulators for prevention and treatment of physiological disorders; drug screening |
| 09/22/2005 | US20050208569 Human stanniocalcin-alpha |
| 09/22/2005 | US20050208566 Using enzymatic membrane protein as tool in identifying modulators for prevention and treatment of atherosclerotic, inflammatory and cell proliferative disorders |
| 09/22/2005 | US20050208565 29 human cancer associated proteins |
| 09/22/2005 | US20050208563 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 09/22/2005 | US20050208562 Guanosine triphosphatase protein for use as tool in diagnosis and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208551 Novel PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 09/22/2005 | US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208545 Nervous system polypeptide for identifying modulators for treatment and prevention of neurodegenerative disorders |
| 09/22/2005 | US20050208544 Diagnostic tests for the detection of peripheral neuropathy |
| 09/22/2005 | US20050208540 Novel fibroblast growth factor and nucleic acids encoding same |
| 09/22/2005 | US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 09/22/2005 | US20050208535 Using retinol binding protein 4 (RBP4)/transthyretin complex formation as tool in identifying modulators of eating and pancreatic disorders |
| 09/22/2005 | US20050208533 Modulators of morphogen expression and methods of identifying the same |
| 09/22/2005 | US20050208526 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208524 Full-length expressed genetic marker (FLEXGEM) polypeptide for use as diagnostic indicator of cell proliferative disorders |
| 09/22/2005 | US20050208523 Compositions and methods for the diagnosis and treatment of tumor |
| 09/22/2005 | US20050208522 Fibroblast growth factor-like molecules and uses thereof |
| 09/22/2005 | US20050208521 Modulation signal transduction; isolated nucleic acids; genetic engineering |
| 09/22/2005 | US20050208514 Novel fibroblast growth factor and nucleic acids encoding dame |
| 09/22/2005 | US20050208509 Expression vector comprising nucleotide sequences coding thermal hysteresis protein for use as tool in lowering freezing point in cells; freeze protection; de-icying solutions |
| 09/22/2005 | US20050208508 Gene encoding labyrinthin, a marker for cancer |
| 09/22/2005 | US20050208507 Human RPS6KA6-related gene variant associated with lung cancers |
| 09/22/2005 | US20050208498 Killer cell immunoglobulin-like receptor (KIR)-like protein receptor for use in diagnosis, prevention and treatment of cancer, autoimmune disease, organ transplant rejection, allergic reaction, and inflammatory disorders |
| 09/22/2005 | US20050208494 Novel proteins and dnas thereof |
| 09/22/2005 | US20050208490 Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof |
| 09/22/2005 | US20050208488 Methods and materials relating to novel von willerband/thrombospondin-like polypeptides and polynucleotides |
| 09/22/2005 | US20050208485 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes and uses thereof |
| 09/22/2005 | US20050208482 Tat-based immunomodulatory compositions and methods for their discovery and use |
| 09/22/2005 | US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection |
| 09/22/2005 | US20050208480 aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | US20050208121 Polymeric cannulae proteins, nucleic acids encoding them and methods for making and using them |
| 09/22/2005 | US20050208079 Glucan-based vaccines |
| 09/22/2005 | US20050208074 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 09/22/2005 | US20050208072 Preventive and therapeutic aids vaccines |
| 09/22/2005 | US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 09/22/2005 | US20050208069 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 09/22/2005 | US20050208068 Malaria immunogen and vaccine |
| 09/22/2005 | US20050208067 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 09/22/2005 | US20050208066 Fusion proteins; severe acute respiratory syndrome coronavirus; double-stranded RNA; drug screening |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208062 Compositions and methods relating to hepatic specific genes and proteins |
| 09/22/2005 | US20050208061 Treatment of autoimmune diseases by oral administration of autoantigens |
| 09/22/2005 | US20050208059 121P1F1: a tissue specific protein highly expressed in various cancers |
| 09/22/2005 | US20050208057 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/22/2005 | US20050208053 Administering very late antigen-4, antigen binding fragment thereof, soluble vascular cell adhesion molecule-1 polypeptide; chimera |
| 09/22/2005 | US20050208052 Screening for agonists/antagonists of interleukins; influenza virus; RNA interference; kits |
| 09/22/2005 | US20050208051 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof |
| 09/22/2005 | US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease |
| 09/22/2005 | US20050208047 Comprises nucleotide sequences coding g protein-coupled receptor associated with nociceptive sensory neuron perception of injury; identifying modulators for treatment of chronic pain |
| 09/22/2005 | US20050208046 TWEAK receptor |
| 09/22/2005 | US20050208045 Augment signaling of ligand of receptor serine kinase in a cell, inhibit formation of complexes between developmental oncoprotein and ligand on the surface of cell |
| 09/22/2005 | US20050208044 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 09/22/2005 | US20050208040 Polynucleotides and polypeptides encoded thereby |
| 09/22/2005 | US20050208039 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 09/22/2005 | US20050208032 Oral administration of therapeutic agent coupled to transporting agent |
| 09/22/2005 | US20050208030 Myocardial grafts and cellular compositions useful for same |
| 09/22/2005 | US20050208023 Inhibiting tumor angiogenesis by engineered over expression of Von Hippel-Lindau; nucleic acid vector is in a viral capsid; administered intratumorally |
| 09/22/2005 | US20050208022 Gene introduced into a retinal cell, encoding photosensitive protein; horizontal cells, amacrine cells, bipolar cells, and ganglion cells; photoreceptor cell degeneration; retinitis pigmentosa, macular degeneration, age-related macular degeneration |
| 09/22/2005 | US20050208021 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same |
| 09/22/2005 | US20050208018 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth |
| 09/22/2005 | US20050208016 derivatives effectively block the inflammatory effects of RANTES, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, and rheumatoid arthritis, hiv |
| 09/22/2005 | US20050208011 Hair follicle growth |
| 09/22/2005 | US20050207995 Methods and compositions for promoting oral health, and polypeptides useful for same |
| 09/22/2005 | US20050205833 Recombinant peptide |
| 09/22/2005 | DE102004010928A1 Enriching prokaryotic DNA from solution, useful e.g. for early diagnosis of bacterial infection, by treatment with protein that binds selectively to non-methylated CpG motifs then separating the complex formed |
| 09/22/2005 | DE102004010023A1 Bakterielles System zum Proteintransport in eukaryontische Zellen Bacterial system for protein delivery into eukaryotic cells |
| 09/22/2005 | CA2564614A1 Combinatorial interleukin-2 muteins |
| 09/22/2005 | CA2559887A1 Method for inhibiting immune complex formation in a subject |
| 09/22/2005 | CA2559390A1 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 09/22/2005 | CA2559172A1 Therapeutic use of rm1 antigen |
| 09/22/2005 | CA2559144A1 Estrogen receptor alpha splice variant er-.alpha.36 |